Guido Reifenberger

发表

DNA methylation-based classification of central nervous system tumours

Till Acker, Pieter Wesseling, Martin Sill, 2018, Nature.

LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS

Colin Watts, Marion Smits, Andrew E. Sloan, 2019, Nature.

Brain tumor imaging with [18F]fluoroethyl-L-tyrosine and PET

Michael Sabel, Kurt Hamacher, Heinz H. Coenen, 2006 .

Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

Roland Eils, Thomas Zichner, Hans Lehrach, 2016, Nature Medicine.

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.

Axel Benner, Stefan Joos, Andrey Korshunov, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort

Volker Hovestadt, Stefan M. Pfister, Paul A. Northcott, 2014, Acta Neuropathologica.

BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1

Rainer König, Volker Hovestadt, Ralf Kemkemer, 2013, Nature Medicine.

Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas

Kai Stühler, Guido Reifenberger, M. Wolter, 2010, Brain pathology.

Comparison of (18)F-FET and (18)F-FDG PET in brain tumors.

Lutz Tellmann, Karl-Josef Langen, Hans Herzog, 2009, Nuclear medicine and biology.

Neurotransmitter Receptor Imbalances in Motor Cortex and Basal Ganglia in Hepatic Encephalopathy

Karl Zilles, Nicola Palomero-Gallagher, Axel Schleicher, 2009, Cellular Physiology and Biochemistry.

Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.

Michael Weller, Wolfgang Wick, Guido Reifenberger, 2012, Neuro-oncology.

Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival

Michael Sabel, Andrey Korshunov, Bernhard Radlwimmer, 2009, Clinical Cancer Research.

Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal residual enhancing tumor load after surgery

Walter Stummer, Peter Martus, Guido Reifenberger, 2012, Journal of Neuro-Oncology.

Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide.

Martin Glas, Michael Weller, Johannes Rieger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

cIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates

Pieter Wesseling, Arie Perry, Andreas von Deimling, 2019, Brain pathology.

Dissecting the genomic complexity underlying medulloblastoma

Matthew J. Betts, Robert B. Russell, Roland Eils, 2012, Nature.

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

Volker Hovestadt, Stefan M. Pfister, Felix Sahm, 2015, Acta Neuropathologica.

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

Volker Hovestadt, Stefan M. Pfister, Paul A. Northcott, 2013, Acta Neuropathologica.

Characteristic Chromosomal Imbalances in Primary Central Nervous System Lymphomas of the Diffuse Large B‐Cell Type

Peter Lichter, Guido Reifenberger, Ralf Weigel, 2000, Brain pathology.

Role of O-(2-18F-Fluoroethyl)-l-Tyrosine PET as a Diagnostic Tool for Detection of Malignant Progression in Patients with Low-Grade Glioma

Gereon R Fink, Karl-Josef Langen, Marion Rapp, 2013, The Journal of Nuclear Medicine.

Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial.

Martin Sill, Michael Platten, Volker Hovestadt, 2014, Neuro-oncology.

Molecular genetic alterations in glioblastomas with oligodendroglial component

Thomas Klockgether, Guido Reifenberger, Martina Beck, 2001, Acta Neuropathologica.

Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016

Guido Reifenberger, G. Reifenberger, Bastian Malzkorn, 2016, Current opinion in oncology.

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas.

Karl-Josef Langen, Guido Reifenberger, Dirk Pauleit, 2005, Brain : a journal of neurology.

Influencing the Wnt signaling pathway in multiple myeloma.

Desheng Lu, Guido Reifenberger, G. Reifenberger, 2011, Anticancer research.

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Gabriele Schackert, Markus Loeffler, Hans Binder, 2015, Acta Neuropathologica.

Glioblastoma: pathology, molecular mechanisms and markers

Gelareh Zadeh, Andreas von Deimling, Guido Reifenberger, 2015, Acta Neuropathologica.

Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real‐time reverse transcription‐polymerase chain reaction

Guido Reifenberger, Jörg van den Boom, M. Wolter, 2006, International journal of cancer.

Molecular diagnostics of brain tumors

Pieter Wesseling, Guido Reifenberger, G. Reifenberger, 2010, Acta Neuropathologica.

Panel Review of Anaplastic Oligodendroglioma From European Organization for Research and Treatment of Cancer Trial 26951: Assessment of Consensus in Diagnosis, Influence of 1p/19q Loss, and Correlations With Outcome

Caterina Giannini, Ping-Pin Zheng, Felice Giangaspero, 2007, Journal of neuropathology and experimental neurology.

The WHO Classification of Tumors of the Nervous System

Webster K. Cavenee, David N. Louis, Guido Reifenberger, 2002 .

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

Andrey Korshunov, Nada Jabado, David T. W. Jones, 2012, Acta Neuropathologica.

International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

Pieter Wesseling, Arie Perry, Caterina Giannini, 2014, Brain pathology.

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.

Roland Eils, Rainer König, Gary D Bader, 2014, Cancer cell.

Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?

Karl-Josef Langen, N Jon Shah, Hubertus Hautzel, 2004, Journal of magnetic resonance imaging : JMRI.

Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel

Guido Reifenberger, M. Wolter, G. Reifenberger, 2017, Brain pathology.

Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin.

Arie Perry, Rakesh Nagarajan, Mark A Watson, 2007, Cancer research.

Molecular characterization of long‐term survivors of glioblastoma using genome‐ and transcriptome‐wide profiling

Gabriele Schackert, Andreas von Deimling, Markus Loeffler, 2014, International journal of cancer.

Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.

Hans-Jakob Steiger, Walter Stummer, Hans-Jörg Wittsack, 2005, Journal of neurosurgery.

Molecular pathogenesis of meningiomas

Arie Perry, David H. Gutmann, Guido Reifenberger, 2004, Journal of Neuro-Oncology.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

Roland Eils, Thomas Zichner, Hans Lehrach, 2013, Nature Genetics.

Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.

Stefan Joos, Thomas Mikeska, Pearlly S Yan, 2010, Cancer research.

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

Gereon R. Fink, Karl-Josef Langen, Martin Kocher, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Amplification and Expression of Cyclin D Genes (CCND1 CCND2 and CCND3) in Human Malignant Gliomas

Peter Lichter, Guido Reifenberger, G. Reifenberger, 1999, Brain pathology.

Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.

Emmanuel Barillot, Arnau Montagud, Loredana Martignetti, 2018, Cancer cell.

Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity

Volker Hovestadt, Stefan M. Pfister, Andrey Korshunov, 2015, Acta Neuropathologica.

Long-term survival with glioblastoma multiforme.

Gabriele Schackert, Andreas von Deimling, Barbara Klink, 2007, Brain : a journal of neurology.

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis.

Gabriele Schackert, Michael Sabel, Matthias Schlesner, 2019, Cancer cell.

Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.

Axel Benner, Stefan Joos, Andrey Korshunov, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Christian Mawrin, Michael Weller, Christian Hartmann, 2009, Acta Neuropathologica.

Oligodendroglioma: Toward Molecular Definitions in Diagnostic Neuro‐Oncology

David N Louis, Guido Reifenberger, G. Reifenberger, 2003, Journal of neuropathology and experimental neurology.

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

Stefan M. Pfister, Damian Stichel, Felix Sahm, 2018, Acta Neuropathologica.

Pten signaling in gliomas.

Guido Reifenberger, G. Reifenberger, A. Merlo, 2002, Neuro-oncology.

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.

Arie Perry, Mark A Watson, Michael R Chicoine, 2005, Cancer research.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Roland Eils, Pieter Wesseling, Martin Sill, 2016, Cell.

The Usefulness of Dynamic O-(2-18F-Fluoroethyl)-l-Tyrosine PET in the Clinical Evaluation of Brain Tumors in Children and Adolescents

Gereon R Fink, Ian Law, Hans-Jakob Steiger, 2015, The Journal of Nuclear Medicine.

Histological classification and molecular genetics of meningiomas

Arie Perry, Guido Reifenberger, G. Reifenberger, 2006, The Lancet Neurology.

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

Kirsten Schmieder, Pieter Wesseling, Andrey Korshunov, 2011, Acta Neuropathologica.

Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas

Michael Sabel, Karl-Josef Langen, Walter Stummer, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Nos2 Inactivation Promotes the Development of Medulloblastoma in Ptch1+/− Mice by Deregulation of Gap43–Dependent Granule Cell Precursor Migration

Nicolas Delhomme, Grischa Toedt, Peter Lichter, 2012, PLoS genetics.

Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma

Thomas Beez, Karl-Josef Langen, Marion Rapp, 2013, The Journal of Nuclear Medicine.

Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling

Volker Hovestadt, Stefan M. Pfister, Paul A. Northcott, 2015, Nature Communications.

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

Martin Sill, Alexander Radbruch, Volker Hovestadt, 2014, Acta Neuropathologica.

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

Pieter Wesseling, Christine Haberler, Arie Perry, 2020, Brain pathology.